AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
IS THE 308-POLYMORPHISM IN THE TUMOR-NECROSIS-FACTOR(ALPHA) (TNF-ALPHA) PROMOTER REGION A MARKER OF DISEASE SUSCEPTIBILITY IN EUROPEAN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC)
Authors: MITCHELL SA SPURKLAND A BOBERG K CHAPMAN RW FLEMING KA SCHRUMPF E
Citation: Sa. Mitchell et al., IS THE 308-POLYMORPHISM IN THE TUMOR-NECROSIS-FACTOR(ALPHA) (TNF-ALPHA) PROMOTER REGION A MARKER OF DISEASE SUSCEPTIBILITY IN EUROPEAN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC), Hepatology, 28(4), 1998, pp. 302-302
HLA CLASS-II HAPLOTYPES IN PRIMARY SCLEROSING CHOLANGITIS PATIENTS FROM 5 ETHNIC-GROUPS
Authors: SAARINEN S BOBERG KM SPURKLAND A MITCHELL S BROOME U ROSINA F CHAPMAN R PARES A OLERUP O SCHRUMPF E
Citation: S. Saarinen et al., HLA CLASS-II HAPLOTYPES IN PRIMARY SCLEROSING CHOLANGITIS PATIENTS FROM 5 ETHNIC-GROUPS, Hepatology, 28(4), 1998, pp. 1130-1130
PROGNOSTIC INDICATORS OF PRIMARY SCLEROSING CHOLANGITIS DETERMINED BYA COX PHASE-SPECIFIC TIME-DEPENDENT MODEL
Authors: BOBERG KM ROCCA G SPURKLAND A BROOME U CHAPMAN R MITCHELL S PARES A ROSINA F SCHRUMPF E
Citation: Km. Boberg et al., PROGNOSTIC INDICATORS OF PRIMARY SCLEROSING CHOLANGITIS DETERMINED BYA COX PHASE-SPECIFIC TIME-DEPENDENT MODEL, Hepatology, 28(4), 1998, pp. 1132-1132
TOPIRAMATE AND FULMINANT LIVER-FAILURE
Authors: BJORO K GJERSTAD L BENTDAL O OSNES S SCHRUMPF E
Citation: K. Bjoro et al., TOPIRAMATE AND FULMINANT LIVER-FAILURE, Lancet, 352(9134), 1998, pp. 1119-1119
THE INTERNET - FRIEND OR FOE TO SCIENTIFIC JOURNALS
Authors: AABAKKEN L SCHRUMPF E SOREIDE O
Citation: L. Aabakken et al., THE INTERNET - FRIEND OR FOE TO SCIENTIFIC JOURNALS, Scandinavian journal of gastroenterology, 33(3), 1998, pp. 223-223
THE 1997 REPORT OF SCANDINAVIAN-JOURNAL-OF-GASTROENTEROLOGY
Authors: SCHRUMPF E SOREIDE O AABAKKEN L
Citation: E. Schrumpf et al., THE 1997 REPORT OF SCANDINAVIAN-JOURNAL-OF-GASTROENTEROLOGY, Scandinavian journal of gastroenterology, 33(1), 1998, pp. 1-1
DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - A COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES
Authors: BANSI DS BAUDUCCI M BERGQVIST A BOBERG K BROOME U CHAPMAN R FLEMING K JORGENSEN R LINDOR K ROSINA F SCHRUMPF E
Citation: Ds. Bansi et al., DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS - A COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES, European journal of gastroenterology & hepatology, 9(6), 1997, pp. 575-580
HOW TO REPORT RANDOMIZED CONTROLLED TRIALS - THE CONSORT STATEMENT
Authors: SCHRUMPF E SOREIDE O AABAKKEN L
Citation: E. Schrumpf et al., HOW TO REPORT RANDOMIZED CONTROLLED TRIALS - THE CONSORT STATEMENT, Scandinavian journal of gastroenterology, 32(12), 1997, pp. 1185-1186
INTERFERON-ALPHA-2B THERAPY IN LOW-ACTIVITY HEPATITIS-C - A PILOT-STUDY
Authors: NORDOY I KRARUP HB BELL H CHRISTENSEN PB ELGJO K VONDERLIPPE B DEMUCKADELL OS MAELAND A RINGLARSEN H SAMDAL HH SIMMONDS P SKAUG K TAGEJENSEN U SCHRUMPF E
Citation: I. Nordoy et al., INTERFERON-ALPHA-2B THERAPY IN LOW-ACTIVITY HEPATITIS-C - A PILOT-STUDY, Scandinavian journal of gastroenterology, 32(12), 1997, pp. 1256-1260
UNTITLED
Authors: SCHRUMPF E SOREIDE O AABAKKEN L
Citation: E. Schrumpf et al., UNTITLED, Scandinavian journal of gastroenterology, 32(1), 1997, pp. 1-1
PRIMARY SCLEROSING CHOLANGITIS - BENEFITS AND DOWNSIDES OF EC SUPPORT
Authors: SCHRUMPF E
Citation: E. Schrumpf, PRIMARY SCLEROSING CHOLANGITIS - BENEFITS AND DOWNSIDES OF EC SUPPORT, Gut, 41, 1997, pp. 65-65
WORLDWIDE PROFILES OF ANTINUCLEAR ANTIBODY CLUSTERS IN AUTOIMMUNE HEPATITIS TYPE-I AND TYPE-II
Authors: NISHIOKA M MORSHED SA PARVEEN S KODAMA T BIANCHI FB CZAJA AJ KRAWITT EL HOMBERG JC MACFARLANE IG VERGANI D BERG PA MANNS MP PENNER E SCHRUMPF E
Citation: M. Nishioka et al., WORLDWIDE PROFILES OF ANTINUCLEAR ANTIBODY CLUSTERS IN AUTOIMMUNE HEPATITIS TYPE-I AND TYPE-II, Hepatology, 24(4), 1996, pp. 432-432
K-RAS MUTATIONS IN CHOLANGIOCARCINOMAS DEVELOPING IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Authors: BOBERG KM FAUSA O SCHJOLBERG A SCHRUMPF E CLAUSEN OPF
Citation: Km. Boberg et al., K-RAS MUTATIONS IN CHOLANGIOCARCINOMAS DEVELOPING IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, Hepatology, 24(4), 1996, pp. 1376-1376
FEATURES OF AUTOIMMUNE HEPATITIS IN PRIMARY SCLEROSING CHOLANGITIS - AN EVALUATION OF 114 PRIMARY SCLEROSING CHOLANGITIS PATIENTS ACCORDINGTO A SCORING SYSTEM FOR THE DIAGNOSIS OF AUTOIMMUNE HEPATITIS
Authors: BOBERG KM FAUSA O HAALAND T HOLTER E MELLBYE OJ SPURKLAND A SCHRUMPF E
Citation: Km. Boberg et al., FEATURES OF AUTOIMMUNE HEPATITIS IN PRIMARY SCLEROSING CHOLANGITIS - AN EVALUATION OF 114 PRIMARY SCLEROSING CHOLANGITIS PATIENTS ACCORDINGTO A SCORING SYSTEM FOR THE DIAGNOSIS OF AUTOIMMUNE HEPATITIS, Hepatology, 23(6), 1996, pp. 1369-1376
DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES
Authors: BANSI D BOBERG K BROOME U CHAPMAN R FLEMING K JORGENSEN R LINDOR K SCHRUMPF E
Citation: D. Bansi et al., DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES, Gastroenterology, 110(4), 1996, pp. 1146-1146
DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES
Authors: BANSI D BOBERG K BROOME U CHAPMAN R FLEMING K JORGENSEN R LINDOR K SCHRUMPF E
Citation: D. Bansi et al., DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES, Hepatology, 22(4), 1995, pp. 1140-1140
INVOLVEMENT OF GUANYLATE-CYCLASE AND PHOSPHODIESTERASES IN THE FUNCTIONAL-HETEROGENEITY OF HUMAN BLOOD-PLATELET SUBPOPULATIONS
Authors: OPPER C SCHRUMPF E GEAR ARL WESEMANN W
Citation: C. Opper et al., INVOLVEMENT OF GUANYLATE-CYCLASE AND PHOSPHODIESTERASES IN THE FUNCTIONAL-HETEROGENEITY OF HUMAN BLOOD-PLATELET SUBPOPULATIONS, Thrombosis research, 80(6), 1995, pp. 461-470
INTERFERON-ALPHA-2B, WITH OR WITHOUT PRIOR HEPATIC-ARTERY EMBOLIZATION - CLINICAL-RESPONSE AND SURVIVAL IN MIDGUT CARCINOID PATIENTS - THE NORWEGIAN CARCINOID STUDY
Authors: JACOBSEN MB HANSSEN LE KOLMANNSKOG F SCHRUMPF E VATN MH BERGAN A
Citation: Mb. Jacobsen et al., INTERFERON-ALPHA-2B, WITH OR WITHOUT PRIOR HEPATIC-ARTERY EMBOLIZATION - CLINICAL-RESPONSE AND SURVIVAL IN MIDGUT CARCINOID PATIENTS - THE NORWEGIAN CARCINOID STUDY, Scandinavian journal of gastroenterology, 30(8), 1995, pp. 789-796
HEPATIC RETENTION OF COPPER AND SELENIUM IN PRIMARY SCLEROSING CHOLANGITIS
Authors: AASETH J THOMASSEN Y AADLAND E FAUSA O SCHRUMPF E
Citation: J. Aaseth et al., HEPATIC RETENTION OF COPPER AND SELENIUM IN PRIMARY SCLEROSING CHOLANGITIS, Scandinavian journal of gastroenterology, 30(12), 1995, pp. 1200-1203
2 DOSE REGIMENS OF RECOMBINANT INTERFERON-ALPHA-2B IN CHRONIC HEPATITIS-C VIRUS-INFECTION - BIOCHEMISTRY, HEPATITIS-C VIRUS RNA, AND LIVER HISTOLOGY AS RESPONSE INDICES
Authors: BJORO K KRARUP H BELL H CHRISTOPHERSEN P EVENSEN S FROLAND SS LAURSEN A VANDERLIPPE B MAELAND A RANEK L RINGLARSEN H SCHOU G SCHRUMPF E TYGSTRUP N
Citation: K. Bjoro et al., 2 DOSE REGIMENS OF RECOMBINANT INTERFERON-ALPHA-2B IN CHRONIC HEPATITIS-C VIRUS-INFECTION - BIOCHEMISTRY, HEPATITIS-C VIRUS RNA, AND LIVER HISTOLOGY AS RESPONSE INDICES, Scandinavian journal of gastroenterology, 30(11), 1995, pp. 1119-1124
MONSTROUS ASCITES IN HEREDITARY HEMORRHAGIC TELANGIECTASIA
Authors: BJORO K SCHRUMPF E ELGJO K KOLMANSKOG F
Citation: K. Bjoro et al., MONSTROUS ASCITES IN HEREDITARY HEMORRHAGIC TELANGIECTASIA, Scandinavian journal of gastroenterology, 30(1), 1995, pp. 92-94
DUPLEX-DOPPLER SONOGRAPHY AND ANGIOGRAPHY IN THE EVALUATION FOR LIVER-TRANSPLANTATION
Authors: KOLMANNSKOG F JAKOBSEN JA SCHRUMPF E BERGEN A
Citation: F. Kolmannskog et al., DUPLEX-DOPPLER SONOGRAPHY AND ANGIOGRAPHY IN THE EVALUATION FOR LIVER-TRANSPLANTATION, Acta radiologica, 35(1), 1994, pp. 1-5
RISK-FACTORS IN PRIMARY SCLEROSING CHOLANGITIS
Authors: SCHRUMPF E ABDELNOOR M FAUSA O ELGJO K JENSSEN E KOLMANNSKOG F
Citation: E. Schrumpf et al., RISK-FACTORS IN PRIMARY SCLEROSING CHOLANGITIS, Journal of hepatology, 21(6), 1994, pp. 1061-1066
IS A 3-DAY WAITING LIST APPROPRIATE FOR PATIENTS WITH ACUTE LIVER-FAILURE
Authors: HOCKERSTEDT K ISONIEMI H ERICZON BG BROOME U FRIMAN S PERSSON H BERGAN A SCHRUMPF E KIRKEGAARD P HJORTRUP A KEIDING S
Citation: K. Hockerstedt et al., IS A 3-DAY WAITING LIST APPROPRIATE FOR PATIENTS WITH ACUTE LIVER-FAILURE, Transplantation proceedings, 26(3), 1994, pp. 1786-1787
HEPATOBILIARY DISEASE IN ULCERATIVE-COLITIS - AN ANALYSIS OF 18 PATIENTS WITH HEPATOBILIARY LESIONS CLASSIFIED AS SMALL-DUCT PRIMARY SCLEROSING CHOLANGITIS
Authors: BOBERG KM SCHRUMPF E FAUSA O ELGJO K KOLMANNSKOG F HAALAND T HOLTER E
Citation: Km. Boberg et al., HEPATOBILIARY DISEASE IN ULCERATIVE-COLITIS - AN ANALYSIS OF 18 PATIENTS WITH HEPATOBILIARY LESIONS CLASSIFIED AS SMALL-DUCT PRIMARY SCLEROSING CHOLANGITIS, Scandinavian journal of gastroenterology, 29(8), 1994, pp. 744-752
Risultati: 1-25 | 26-29